Clinical Trial: AMX0035 and Progressive Supranuclear Palsy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Progressive Supranuclear Palsy
Study Type: INTERVENTIONAL
Official Title: A Phase 3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION)
Brief Summary:
ORION Trial is a trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of a randomized double blind placebo controlled phase, followed by an optional open-label extension phase.
Read more